Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma
Clinical trial NCT01248975 · COMPLETED
Trial details
- NCT number
- NCT01248975
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-10-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.